- Home
- HOFT vs NRXP Comparison
HOFT vs NRXP Comparison
Compare HOFT & NRXP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | HOFT | NRXP |
|---|---|---|
| Founded | 1924 | 2015 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Home Furnishings | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 139.4M | 151.1M |
| IPO Year | 1999 | 2017 |
Fundamental Metrics
Financial Performance| Metric | HOFT | NRXP |
|---|---|---|
| Price | $13.26 | $2.66 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 4 |
| Target Price | $16.50 | ★ $38.50 |
| AVG Volume (30 Days) | 25.7K | ★ 663.9K |
| Earning Date | 12-10-2026 | 11-16-2026 |
| Dividend Yield | ★ 3.53% | N/A |
| EPS Growth | N/A | ★ 69.70 |
| EPS | ★ 0.25 | N/A |
| Revenue | N/A | ★ $1,225,000.00 |
| Revenue This Year | N/A | $357.94 |
| Revenue Next Year | $14.16 | $1,507.30 |
| P/E Ratio | $52.04 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $8.88 | $1.65 |
| 52 Week High | $18.09 | $5.06 |
Technical Indicators
Market Signals| Indicator | HOFT | NRXP |
|---|---|---|
| Relative Strength Index (RSI) | 56.56 | 42.68 |
| Support Level | $13.09 | $1.68 |
| Resistance Level | $13.46 | $3.62 |
| Average True Range (ATR) | 0.37 | 0.17 |
| MACD | 0.07 | 0.02 |
| Stochastic Oscillator | 65.83 | 62.32 |
Price Performance
Historical ComparisonAbout HOFT Hooker Furnishings Corporation
Hooker Furnishings Corp is a designer, marketer, and importer of casegoods (wooden and metal furniture), leather furniture, fabric-upholstered furniture, lighting, accessories, and home decor for the residential, hospitality, and contract markets. It is also domestically manufactured premium residential custom leather, custom fabric-upholstered furniture, and outdoor furniture. The company operates in four segments: Hooker Branded segment, Domestic Upholstery segment, and All Other. It generates the majority of its revenue from the Hooker Branded segment.
About NRXP NRX Pharmaceuticals Inc.
NRX Pharmaceuticals Inc is a clinical-stage, small-molecule pharmaceutical company that develops and plans to distribute novel therapeutics for the treatment of central nervous system disorders and life-threatening pulmonary diseases. The company is developing NRX-100/101, the first sequential drug regimen for bipolar depression in patients with acute suicidal ideation and behavior.